JP2025505673A5 - - Google Patents

Info

Publication number
JP2025505673A5
JP2025505673A5 JP2024547086A JP2024547086A JP2025505673A5 JP 2025505673 A5 JP2025505673 A5 JP 2025505673A5 JP 2024547086 A JP2024547086 A JP 2024547086A JP 2024547086 A JP2024547086 A JP 2024547086A JP 2025505673 A5 JP2025505673 A5 JP 2025505673A5
Authority
JP
Japan
Prior art keywords
peptide
pharmaceutical composition
composition according
mutations
mutant strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505673A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012488 external-priority patent/WO2023150375A2/en
Publication of JP2025505673A publication Critical patent/JP2025505673A/ja
Publication of JP2025505673A5 publication Critical patent/JP2025505673A5/ja
Pending legal-status Critical Current

Links

JP2024547086A 2022-02-07 2023-02-07 Ｃｏｖｉｄ感染症を処置するための方法および組成物 Pending JP2025505673A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263307371P 2022-02-07 2022-02-07
US63/307,371 2022-02-07
US202217870174A 2022-07-21 2022-07-21
US202217870158A 2022-07-21 2022-07-21
US17/870,174 2022-07-21
US17/870,158 2022-07-21
PCT/US2023/012488 WO2023150375A2 (en) 2022-02-07 2023-02-07 Methods and compositions for treating covid infections

Publications (2)

Publication Number Publication Date
JP2025505673A JP2025505673A (ja) 2025-02-28
JP2025505673A5 true JP2025505673A5 (https=) 2026-02-03

Family

ID=87552901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547086A Pending JP2025505673A (ja) 2022-02-07 2023-02-07 Ｃｏｖｉｄ感染症を処置するための方法および組成物

Country Status (4)

Country Link
EP (1) EP4475868A2 (https=)
JP (1) JP2025505673A (https=)
CN (1) CN119156396A (https=)
WO (1) WO2023150375A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022159372A1 (en) * 2021-01-22 2022-07-28 Decoy Therapeutics, Inc. Methods and compositions for treating infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022551813A (ja) * 2019-09-04 2022-12-14 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 麻疹に対する併用抗ウイルス療法
US20230285539A1 (en) * 2020-03-06 2023-09-14 Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Vaccines against sars-cov-2 and other coronaviruses
AU2021244228A1 (en) * 2020-03-25 2022-11-17 Biohaven Therapeutics Ltd. Technologies for preventing or treating infections
WO2021207517A2 (en) * 2020-04-10 2021-10-14 Sapience Therapeutics, Inc. Modified hr2 peptide inhibitors of coronavirus fusion
US11180534B1 (en) * 2021-06-04 2021-11-23 Morehouse School Of Medicine Compositions and methods for treating SARS-CoV-2 infections

Similar Documents

Publication Publication Date Title
US5990093A (en) Treating HBV with phospholipid prodrugs of β-L-2',3'-dideoxyadenosine 5'-monophosphate
US6509154B1 (en) Product comprising at least a double stranded RNA combined with at least an antiviral agent
JP4413996B2 (ja) 抗ｂ型肝炎ウィルス活性を有するヌクレオシド
JP2009504157A5 (https=)
CN1049357C (zh) 利用双链核糖核酸与病毒抑制剂联合以治疗人的病毒感染
JP2010503396A5 (https=)
JP2818299B2 (ja) ウイルス感染の治療におけるジデオキシヌクレオシドアナローグの使用
JP2024503265A5 (https=)
EP0844878A1 (en) 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
WO2001032153A2 (en) Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
JP2009535352A5 (https=)
JPH0125A (ja) ｄｓＲＮＡと逆転写酵素インヒビターを含んで成るＨＩＶ感染治療のための医薬組成物
JP2004509061A5 (https=)
JP2023534524A5 (https=)
JP2024170583A5 (https=)
FI3534939T3 (fi) Rokote sian parvovirusta ja sian hedelmättömyyttä ja respiratorista oireyhtymää aiheuttamaa virusta vastaan ja menetelmän sen valmistamiseksi
JP2008523098A5 (https=)
JP2005527547A5 (https=)
WO1997035591B1 (en) Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
EA201000085A1 (ru) dsPHK, ПРЕДНАЗНАЧЕННАЯ ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ИНФЕКЦИИ
JP2025505673A5 (https=)
JP2005526833A5 (https=)
PH12022552516A1 (en) Pharmaceutical composition for preventing or treating epidemic rna viral infectious disease
JP2024504225A5 (https=)
Sabroe et al. Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin.